03/17/2025
3:30 PM | DiaMedica Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
7:30 AM | DiaMedica Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
4:06 PM | DiaMedica Therapeutics (Issuer)
O'Connor Daniel J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
3:46 PM | DiaMedica Therapeutics (Issuer)
Parsons James T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:31 PM | DiaMedica Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:32 PM | DiaMedica Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
11:15 PM | DiaMedica Therapeutics (Filer)
| Form EFFECT | |
07/18/2024
4:28 PM | DiaMedica Therapeutics (Filer)
| Form 424B3 | |
07/10/2024
3:16 PM | DiaMedica Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/08/2024
4:23 PM | DIALECTIC CAPITAL MANAGEMENT, LP (Filed by)
DiaMedica Therapeutics (Subject)
| Form SC 13G | |
07/02/2024
1:25 PM | Daves Julie VanOrsdel (Reporting)
DiaMedica Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
3:24 PM | DiaMedica Therapeutics (Issuer)
STAHLBERG JAN (Reporting)
TRILL AB (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
7:16 AM | DiaMedica Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
7:01 AM | DiaMedica Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
3:41 PM | DiaMedica Therapeutics (Issuer)
Pauls Dietrich John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:29 PM | DiaMedica Therapeutics (Issuer)
Pilnik Richard D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:35 PM | DiaMedica Therapeutics (Issuer)
Semba Charles Pauling (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | DiaMedica Therapeutics (Issuer)
Kuntz Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:14 PM | DiaMedica Therapeutics (Issuer)
Lewis Tanya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:36 PM | DiaMedica Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
11:15 PM | DiaMedica Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
5:12 AM | DiaMedica Therapeutics (Filer)
| Form ARS | |
04/04/2024
5:05 AM | DiaMedica Therapeutics (Filer)
| Form DEF 14A | |
04/04/2024
5:06 AM | DiaMedica Therapeutics (Filer)
| Form DEFA14A | |
Buy DMAC Stock Free DMAC Stock Alerts